CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

66 hedge funds and large institutions have $44.3M invested in Cascadian Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 66 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
66
Holders Change
+66
Holders Change %
% of All Funds
2.15%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
66
Increased
Reduced
Closed
Calls
$3.3M
Puts
$409K
Net Calls
+$2.89M
Net Calls Change
+$2.89M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter